A new strategy for curbing a fungal infection that affects millions of people worldwide has been developed by researchers. The fungal infection, Candidiasis, is caused by the Candida albicans species and is the fourth most common cause of hospital-acquired infections. The researchers have developed a new strategy that uses a combination of antifungal drugs and an inhibitor of fungal cell wall synthesis. The combination therapy is effective at killing the fungal cells and preventing them from spreading and causing further infections. The results of the study provide hope that this new strategy could be used to help reduce the prevalence of this infection and protect vulnerable populations from its effects.

Read Full Article Here

source: Phys.org